Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   HEPATITIS MONTHLY   JUNE 2011 , Volume 11 , Number 6 (35); Page(s) 475 To 476.
 
Paper: 

OCCULT HEPATITIS B: EVOLVING CHALLENGES AND NEW PERSPECTIVES (LETTER TO EDITOR)

 
 
Author(s):  AKARSU MESUT*, KANTAR FUNDA UGUR, SAYINER A ARZU
 
* DOKUZ EYLUL UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF GASTROENTEROLOGY, IZMIR, TURKEY
 
Abstract: 
We read with great interest the article, “efficacy of hepatitis B vaccine in those who lost hepatitis B surface antigen during follow-up” by Taheriet al. published in Hepatitis Monthly (1). In this article, the authors assessed the efficacy of HBV vaccine in those who lost their HBsAg without seroconverssion to anti-HBs antibody with no detectable anti-HBs antibody and HBV DNA in their sera.
They reported that nearly 24% of chronic HBsAg-positive subjects who lost their HBsAg responded to HBV vaccine and the remaining cases need to be followed for occult HBV infection (OBI).
 
Keyword(s): OCCULT HEPATITIS B, HEPATITIS B SURFACE ANTIGEN
 
 
References: 
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

AKARSU, M., & KANTAR, F., & SAYINER, A. (2011). OCCULT HEPATITIS B: EVOLVING CHALLENGES AND NEW PERSPECTIVES (LETTER TO EDITOR). HEPATITIS MONTHLY, 11(6 (35)), 475-476. https://www.sid.ir/en/journal/ViewPaper.aspx?id=200739



Vancouver: Copy

AKARSU MESUT, KANTAR FUNDA UGUR, SAYINER A ARZU. OCCULT HEPATITIS B: EVOLVING CHALLENGES AND NEW PERSPECTIVES (LETTER TO EDITOR). HEPATITIS MONTHLY. 2011 [cited 2021October24];11(6 (35)):475-476. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=200739



IEEE: Copy

AKARSU, M., KANTAR, F., SAYINER, A., 2011. OCCULT HEPATITIS B: EVOLVING CHALLENGES AND NEW PERSPECTIVES (LETTER TO EDITOR). HEPATITIS MONTHLY, [online] 11(6 (35)), pp.475-476. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=200739.



 
  pdf-File
Yearly Visit 68
 
 
Latest on Blog
Enter SID Blog